Calista Therapeutics Overview
- Year Founded
-
2012
- Status
-
Out of Business
- Employees
-
2
- Latest Deal Type
-
Out of Business
Calista Therapeutics General Information
Description
Developer of proprietary peptide drugs intended for cystic fibrosis. The company discovers and develops novel therapeutics that modulate cellular transport and location, and activate membrane receptors, enabling medical professionals to provide improved treatments for people with cystic fibrosis.
Contact Information
Website
www.calistatherapeutics.comCorporate Office
- 32 Riverside Drive
- Lincoln, RI 02865
- United States
Corporate Office
- 32 Riverside Drive
- Lincoln, RI 02865
- United States
Calista Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Out of Business | 09-Aug-2025 | Completed | Out of Business | |||
| 4. Grant | 01-Feb-2021 | Completed | Pre-Clinical Trials | |||
| 3. Grant | 01-Jul-2014 | Completed | Startup | |||
| 2. Grant | 15-Sep-2013 | $225K | Completed | Startup | ||
| 1. Accelerator/Incubator | 22-May-2013 | Completed | Startup |
Calista Therapeutics Patents
Calista Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20210393516-A1 | Solid implant formulation for drug delivery | Inactive | 14-Mar-2019 | ||
| US-20240423906-A1 | Solid implant formulation for drug delivery | Pending | 14-Mar-2019 | ||
| CA-2908103-A1 | Compositions and methods of use for cell targeted inhibitors of the cystic fibrosis transmembrane regulator associated ligand | Inactive | 02-Oct-2015 | ||
| AU-2015234367-A1 | Compositions and methods of use for cell targeted inhibitors of the cystic fibrosis transmembrane regulator associated ligand | Inactive | 01-Oct-2015 | ||
| US-20170114093-A1 | Methods of treatment and prevention of disease by arginine-rich compositions that induce cytoprotection and neuroprotection | Inactive | 29-May-2015 | C07K7/06 |
Calista Therapeutics Signals
Calista Therapeutics FAQs
-
When was Calista Therapeutics founded?
Calista Therapeutics was founded in 2012.
-
Where is Calista Therapeutics headquartered?
Calista Therapeutics is headquartered in Lincoln, RI.
-
What is the size of Calista Therapeutics?
Calista Therapeutics has 2 total employees.
-
What industry is Calista Therapeutics in?
Calista Therapeutics’s primary industry is Drug Discovery.
-
Is Calista Therapeutics a private or public company?
Calista Therapeutics is a Private company.
-
What is Calista Therapeutics’s current revenue?
The current revenue for Calista Therapeutics is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process